FDA approves nasal injection epinephrine for aAnaphylaxis, reaction
Aug. 9 (UPI) — The U.S. Food and Drug Administration on Friday announced the approval of the first nasal spray for treatment of anaphylaxis, a life-threatening allergic reaction. The epinephrine … Click to Continue »
View original article
Contributor:
